Read Time: 3 minutes
The evaluation of Huntsman Cancer Institute鈥檚 Huntsman at Home model was presented today at the American Society of Clinical Oncology Annual Meeting
Researchers at Huntsman Cancer Institute (HCI) at the (U of U) presented the first outcomes evaluation of an adult oncology hospital-at-home program today at the 2020 American Society of Clinical Oncology (ASCO) . The study evaluated patients participating in HCI鈥檚 Huntsman at HomeTM. The data demonstrate strong evidence for this care model, showing improved patient outcomes, including reduced hospitalizations and decreased visits to the emergency department.
Huntsman at HomeTM was launched in 2018 as a way to bring HCI-quality care to cancer patients in their homes. The service combines HCI research and clinical expertise for in-person and remote patient and caregiver support and acute-level clinical treatment. A team of oncology professionals deliver care, following best-practice standards. Currently, Huntsman at HomeTM is available to HCI patients living within a 20-mile radius of the flagship hospital in Salt Lake City.
The lead author of the study is interim senior director of population sciences at HCI and distinguished professor of nursing at the U of U. Mooney and her colleagues evaluated outcomes over 14 months for 367 cancer patients, 169 of whom participated in Huntsman at HomeTM and 198 control patients who qualified for the program, but live outside the service area. Patients with several types of cancer and at various stages of cancer were evaluated. During the first 30 days of enrollment, Huntsman at HomeTM patients were 58% less likely to be admitted for an unplanned hospital stay, and those who were admitted to the hospital had a shorter length of stay. Huntsman at HomeTM patients had 48% less emergency department visits. They also had 48% lower cumulative charges for clinical services when compared to controls. Results over 90 days were similarly robust.
鈥淭hese findings strongly support our hypothesis that Huntsman at Home鈥檚 high-quality, acute-level cancer care using a hospital-at-home model improves outcomes while simultaneously improving value,鈥 said Mooney.
Huntsman at HomeTM services range from symptom management to acute medical, post-surgical, and end-of-life care. The Huntsman at HomeTM team is led by HCI nurse practitioners working in conjunction with HCI oncologists and is operated in partnership with , a home health and hospice agency that provides registered nurses for the team. Other cancer care specialists such as social workers and physical therapists contribute to patient care. Patients must receive a referral from their oncologist and live within a 20-mile radius of HCI.
Mooney and her colleagues plan to continue evaluating outcomes of patients participating in this program. They are also working to implement a geographic expansion of Huntsman at HomeTM in late summer 2020, extending care to several Utah rural counties.
The 2020 ASCO Annual meeting was held virtually from May 29 to May 30. As one of the largest clinical cancer research meetings in the world, ASCO brings together more than 30,000 professionals world-wide for on-demand and scheduled broadcasts of the latest cutting-edge oncology research.
Huntsman at HomeTM is funded by HCI and Huntsman Cancer Foundation. The evaluation of Huntsman at HomeTM is supported by the Cambia Health Foundation. The rural expansion is supported by the Huntsman Foundation and the Rita & Alex Hillman Foundation.
Media Contact
Heather Simonsen
Public Affairs Senior Manager
Huntsman Cancer Institute
801 581-3194
public.affairs@hci.utah.edu
About Huntsman Cancer Institute at the University of Utah
Huntsman Cancer Institute at the is the National Cancer Institute-designated Comprehensive Cancer Center for Utah, Idaho, Montana, Nevada, and Wyoming. With a legacy of innovative cancer research, groundbreaking discoveries, and world-class patient care, we are transforming the way cancer is understood, prevented, diagnosed, treated, and survived. Huntsman Cancer Institute focuses on delivering the most advanced cancer healing and prevention through scientific breakthroughs and cutting-edge technology to advance cancer treatments of the future beyond the standard of care today. We have more than 300 open clinical trials and 250 research teams studying cancer. More genes for inherited cancers have been discovered at Huntsman Cancer Institute than at any other cancer center. Our scientists are world-renowned for understanding how cancer begins and using that knowledge to develop innovative approaches to treat each patient鈥檚 unique disease. Huntsman Cancer Institute was founded by Jon M. and Karen Huntsman.